These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 15339858)

  • 1. CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.
    Spano MS; Fattore L; Cossu G; Deiana S; Fadda P; Fratta W
    Br J Pharmacol; 2004 Oct; 143(3):343-50. PubMed ID: 15339858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
    Fattore L; Spano M; Melis V; Fadda P; Fratta W
    Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
    Fattore L; Spano S; Cossu G; Deiana S; Fadda P; Fratta W
    Neuropharmacology; 2005 Jun; 48(8):1097-104. PubMed ID: 15910886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats.
    Fattore L; Spano MS; Cossu G; Deiana S; Fratta W
    Eur J Neurosci; 2003 Apr; 17(8):1723-6. PubMed ID: 12752390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
    Fattore L; Cossu G; Martellotta CM; Fratta W
    Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats.
    De Vries TJ; Homberg JR; Binnekade R; Raasø H; Schoffelmeer ANM
    Psychopharmacology (Berl); 2003 Jul; 168(1-2):164-169. PubMed ID: 12669182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heroin self-administration under a second-order schedule of reinforcement: acquisition and maintenance of heroin-seeking behaviour in rats.
    Alderson HL; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 2000 Dec; 153(1):120-33. PubMed ID: 11255922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala.
    Alvarez-Jaimes L; Polis I; Parsons LH
    Neuropsychopharmacology; 2008 Sep; 33(10):2483-93. PubMed ID: 18059440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats.
    Economidou D; Mattioli L; Cifani C; Perfumi M; Massi M; Cuomo V; Trabace L; Ciccocioppo R
    Psychopharmacology (Berl); 2006 Jan; 183(4):394-403. PubMed ID: 16261315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR; Koek W
    Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.
    Manzanedo C; Rodríguez-Arias M; Daza-Losada M; Maldonado C; Aguilar MA; Miñarro J
    Behav Brain Funct; 2010 Mar; 6():19. PubMed ID: 20307280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.
    Ward SJ; Rosenberg M; Dykstra LA; Walker EA
    Drug Alcohol Depend; 2009 Dec; 105(3):248-55. PubMed ID: 19679410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats.
    Solinas M; Panlilio LV; Tanda G; Makriyannis A; Matthews SA; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2046-57. PubMed ID: 15870833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the cannabinoid CB1 receptor in the opioid inhibition of the response to cholecystokinin and acute withdrawal response.
    Romanelli L; Palmery M; Tucci P; Amico MC; Morrone LA; Valeri P
    Neurotoxicology; 2005 Oct; 26(5):819-27. PubMed ID: 15913779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats.
    Fattore L; Martellotta MC; Cossu G; Mascia MS; Fratta W
    Behav Brain Res; 1999 Oct; 104(1-2):141-6. PubMed ID: 11125733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones.
    Fattore L; Spano MS; Altea S; Fadda P; Fratta W
    Br J Pharmacol; 2010 Jun; 160(3):724-35. PubMed ID: 20590575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
    Haller J; Varga B; Ledent C; Freund TF
    Behav Pharmacol; 2004 Jul; 15(4):299-304. PubMed ID: 15252281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.